Levin, Fishbein, Sedran & Berman, representing plaintiffs in complex litigation involving serious injuries and/or death

A law firm with a national reputation that provides personalized attention to its clients. Philadelphia’s Levin, Fishbein, Sedran & Berman provides specialized representation to plaintiffs in complex personal injury and class action cases, involving practice areas that include anti-trust, consumer, pharmaceutical and products liability issues, medical malpractice, and other major personal injury cases.

Levin, Fishbein, Sedran & Berman has spearheaded the prosecution efforts of the largest mass tort litigations in the nation. Most recently, the firm was one of six plaintiffs' counsel responsible for negotiating the $4.85 billion settlement with Merck & Co., Inc. involving the widely prescribed drug Vioxx.

Currently the lead plaintiffs’ counsel in the Diet Drug Products Liability Litigation (the “Fen-Phen” litigation) – a nationwide class action with 600,000 class members that will involve $6 billion in benefits – the firm has the ability, experience and knowledge to obtain outstanding results for its clients. It has achieved such results in cases litigated both in the Philadelphia area and nationally, at the trial court level and in appellate courts. Members of the firm have appeared before the United States Supreme Court and have filed numerous petitions before that Court to hear important, fundamental legal issues.

For more than 20 years, Levin, Fishbein, Sedran & Berman has successfully prosecuted hundreds of cases involving drug and pharmaceutical recall claims, defective products liability cases, mass tort and environmental liability exposure claims, and antitrust cases for the plaintiffs it has represented. Many of the cases have been litigated through the specialized Multidistrict Litigation process established by Congress for the consolidation and coordination of cases having common issues.

In addition, the firm also represents individuals who have been seriously injured as a consequence of medical malpractice, vehicular accidents, premises liability and other actions. The firm has litigated such cases in state and federal courts across the country.

Contact Levin, Fishbein, Sedran & Berman to discuss your case.

Important information in IN re: Insurance Brokerage Antitrust Litigation

        > Settlement with Zurich Defendants

A settlement has been reached with the Zurich Defendants, which will provide for the payment of at least $121.8 million to the Settlement Class Members. This proposed settlement has been preliminarily approved by the Court. The Court has scheduled a final approval hearing for January 26, 2007. You may be required to file a Claim Form in order to participate in the settlement. For further information on the settlement, including important deadlines, please visit www.insurancebrokerageantitrustlitigation.com.
For current information on the litigation, please visit www.insurance
brokerageclasscounsel.com. Please click here to view the Notice or click here to view the Claim Form.

Settlement with Arthur J. Gallagher Defendants

On December 29, 2006, a settlement was reached with the Gallagher Defendants which will provide for the payment of at least $28 million to the Settlement Class Members and also will provide for the implementation of certain business reforms, pending approval by the Court. Please click here to view the Notice. For further information, including important deadlines, please visit http://gallaghersettlement.com